Week One Recap: Musk and Altman Face Off in High-Stakes AI Trial
The first week of the Elon Musk vs. Sam Altman trial in Oakland, California, has been marked by tense testimony and mounting stakes. The case centers on Musk's claim that OpenAI betrayed its nonprofit mission when it moved toward for-profit operations.
'Every day brings new evidence of the backroom maneuvering that led to OpenAI's transformation,' said Michelle Kim, a legal expert who has been attending the trial. 'The courtroom is electric with the tension of two AI titans clashing over the soul of their creation.'
What the Case Is Really About
Musk is suing OpenAI, alleging breach of charitable trust. He claims that his initial $50 million investment was intended for a nonprofit dedicated to open-source AI safety. OpenAI counters that Musk repeatedly agreed to a for-profit structure, citing emails and meeting notes.
The central question is whether Musk was deceived or simply changed his mind. 'The statute of limitations is a major battleground,' Kim explained. 'Musk insists he only discovered the alleged misconduct in 2022, well within the four-year window.'
Background
OpenAI was founded in 2015 as a nonprofit with Musk providing significant early funding. In 2018, Musk left the board amid disagreements over direction. By 2023, OpenAI had launched ChatGPT and shifted to a 'capped-profit' model, then proposed a full restructuring in 2025.
The California and Delaware attorneys general approved a compromise in October 2025, reducing the nonprofit's control. Musk seeks to unwind that deal, potentially forcing OpenAI to revert to its original structure.
What This Means
A partial win for Musk could delay OpenAI's planned IPO and shake investor confidence. 'If Musk's suit succeeds, it could force OpenAI to renegotiate its corporate structure, disrupting years of planning,' Kim noted. 'For the broader AI industry, this trial is a test case for how founder intentions can constrain future corporate evolution.'
Outside the courthouse, protesters voice skepticism about both sides. Signs reading 'We all lose' reflect a growing public distrust of big AI firms. The trial resumes next week with testimony from Greg Brockman, OpenAI's president.